Each 5 ml oral suspension contains Magaldrate BP 480mg and Simethicone USP 20mg
This medication is indicated to relieve symptoms of dyspepsia, heartburn, acid indigestion, sour stomach, gastro esophageal reflux and hiatal hernia.it is also prescribed in hyperacidity associated with peptic ulcers, gastritis and esophagitis. Magaldrate may be given to children if necessary. Also indicated for the relief of flatulence, abdominal distension and windy colic.
Each 5 ml oral suspension contains Magaldrate BP 480mg and Simethicone USP 20mg
This medication is indicated to relieve symptoms of dyspepsia, heartburn, acid indigestion, sour stomach, gastro esophageal reflux and hiatal hernia.it is also prescribed in hyperacidity associated with peptic ulcers, gastritis and esophagitis. Magaldrate may be given to children if necessary. Also indicated for the relief of flatulence, abdominal distension and windy colic.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.